Legal Opinion
Alza Corp. v. Mylan Laboratories, Inc.
District Court, N.D. West Virginia
Decided September 27, 2005No. CIV.A. 1:03CV61PublishedCited by 2 opinions
1Opinion of the Court
POST-TRIAL MEMORANDUM OPINION AND ORDER
KEELEY, District Judge.
This is a patent infringement suit involving a pharmaceutical invention disclosed by U.S. Patent No. 6,124,355 (issued Sept. 26, 2000) (“the ’355 patent”). The plaintiff, Alza Corporation (“Alza”), holds title to the ’355 patent. The defendants in this case are Mylan Laboratories, Inc. and My-lan Pharmaceuticals, Inc. (collectively “Mylan”).
Mylan committed acts of infringement by filing two Abbreviated New Drug Applications (“ANDAs”) (Nos. 76-644 & 76-703) with the Food and Drug Administration (“FDA”), seeking permission to…
2Cases cited45 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- American Hoist & Derrick Company, Cross-Appellee v. Sowa & Sons, Inc., Cross-AppellantCourt of Appeals for the Federal Circuit · 1984
- amazon.com, Inc. v. barnesandnoble.com, Inc. And barnesandnoble.com, LLCCourt of Appeals for the Federal Circuit · 2001
- Vas-Cath Incorporated and Gambro, Inc. v. Sakharam D. Mahurkar, and Quinton Instruments CompanyCourt of Appeals for the Federal Circuit · 1991
- The Standard Oil Company, Appellant/cross-Appellee v. American Cyanamid Company, Appellee/cross-AppellantCourt of Appeals for the Federal Circuit · 1985
40 more not listed; retrieve them via the Exa API.
3Cited by2 opinions
- Alza Corporation v. Mylan LaboratoriesCourt of Appeals for the Federal Circuit · 2006
- Forest Laboratories, Inc. v. Ivax Pharmaceuticals, Inc.District Court, D. Delaware · 2006